Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture

Journal of Clinical Virology

Volumn 55, Issue 3, 2012, Pages 220-225

  Larrat, Sylvie ^a,b   Bourdon, Cécile ^a   Baccard, Monique ^a,b   Garnaud, Cécile ^a   Mathieu, Sophie ^a   Quesada, Jean Louis ^a   Signori Schmuck, Anne ^a,b   Germi, Raphaele ^a,b   Blanc, Myriam ^a   Leclercq, Pascale ^a   Hilleret, Marie Noelle ^a,c   Leroy, Vincent ^a,c   Zarski, Jean Pierre ^a,c   Morand, Patrice ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^c INSTITUT ALBERT BONNIOT   (France)

Author keywords

Alternative sampling; Antigen antibody combined detection; Dried blood spots; High risk population; HIV HCV co infection; Oral mucosal transudate

Indexed keywords

CORE PROTEIN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; ENZYME IMMUNOASSAY; EXUDATE; FEMALE; FINGERSTICK BLOOD; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MIXED INFECTION; MOUTH MUCOSA; ORAL MUCOSAL TRANSUDATE; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STORAGE; VEIN PUNCTURE; VIRUS DETECTION;

ADULT; AGED; ANTIGENS, VIRAL; BLOOD; CLINICAL LABORATORY TECHNIQUES; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PHLEBOTOMY; POINT-OF-CARE SYSTEMS; SALIVA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84866346586     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.07.016     Document Type: Article

References (33)

1. Asselah T., Marcellin P. New direct-acting antivirals' combination for the treatment of chronic hepatitis C. Liver Int 2011, 31(Suppl. 1):68-77.
2. Deuffic-Burban S., Mathurin P., Pol S., Larsen C., Roudot-Thoraval F., Desenclos J.C., et al. Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis. Gut 2012, 61:290-296.
3. Matthews G.V., Pham S.T., Hellard M., Grebely J., Zhang L., Oon A., et al. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis 2011, 52:803-811.
4. Hickman M., McDonald T., Judd A., Nichols T., Hope V., Skidmore S., et al. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral Hepat 2008, 15:250-254.
5. White B., Day C., Thein H.H., Doab A., Bates A., Holden J., et al. Acceptability of hepatitis C virus testing methods among injecting drug users. Drug Alcohol Rev 2008, 27:666-670.
6. Anderson D.A., Crowe S.M., Garcia M. Point-of-care testing. Curr HIV/AIDS Rep 2011, 8:31-37.
7. Smith B.D., Drobeniuc J., Jewett A., Branson B.M., Garfein R.S., Teshale E., et al. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis 2011, 204:825-831.
8. Smith B.D., Teshale E., Jewett A., Weinbaum C.M., Neaigus A., Hagan H., et al. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Clin Infect Dis 2011, 53:780-786.
9. Cameron S.O., Carman W.F. The use of the OraSure collection device for hepatitis virus testing in health care settings. J Clin Virol 2005, 34(Suppl. 1):S22-S28.
10. Croom H.A., Richards K.M., Best S.J., Francis B.H., Johnson E.I., Dax E.M., et al. Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots. J Clin Virol 2006, 36:68-71.
11. Gonzalez V., Martro E., Folch C., Esteve A., Matas L., Montoliu A., et al. Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies. Eur J Clin Microbiol Infect Dis 2008, 27:121-126.
12. Hope V.D., Hickman M., Ngui S.L., Jones S., Telfer M., Bizzarri M., et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat 2011, 18:262-270.
13. Judd A., Parry J., Hickman M., McDonald T., Jordan L., Lewis K., et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003, 71:49-55.
14. Sherman K.E., Creager R.L., O'Brien J., Sargent S., Piacentini S., Thieme T. The use of oral fluid for hepatitis C antibody screening. Am J Gastroenterol 1994, 89:2025-2027.
15. Tuaillon E., Mondain A.M., Meroueh F., Ottomani L., Picot M.C., Nagot N., et al. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology 2010, 51:752-758.
16. Miedouge M., Saune K., Kamar N., Rieu M., Rostaing L., Izopet J. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol 2010, 48:18-21.
17. Thomson E.C., Nastouli E., Main J., Karayiannis P., Eliahoo J., Muir D., et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009, 23:89-93.
18. van Doornum G.J., Lodder A., Buimer M., van Ameijden E.J., Bruisten S. Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV RNA in serum. J Med Virol 2001, 64:13-20.
19. Newcombe R.G. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998, 17:873-890.
20. Bouvier-Alias M., Patel K., Dahari H., Beaucourt S., Larderie P., Blatt L., et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 2002, 36:211-218.
21. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
22. Kendrick S.R., Kroc K.A., Withum D., Rydman R.J., Branson B.M., Weinstein R.A. Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J Acquir Immune Defic Syndr 2005, 38:142-146.
23. Lubelchek R., Kroc K., Hota B., Sharief R., Muppudi U., Pulvirenti J., et al. The role of rapid vs. conventional human immunodeficiency virus testing for inpatients: effects on quality of care. Arch Intern Med 2005, 165:1956-1960.
24. Metcalf C.A., Douglas J.M., Malotte C.K., Cross H., Dillon B.A., Paul S.M., et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis 2005, 32:130-138.
25. Spielberg F., Branson B.M., Goldbaum G.M., Lockhart D., Kurth A., Rossini A., et al. Choosing HIV counseling and testing strategies for outreach settings: a randomized trial. J Acquir Immune Defic Syndr 2005, 38:348-355.
26. Lee S.R., Kardos K.W., Schiff E., Berne C.A., Mounzer K., Banks A.T., et al. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. J Virol Methods 2011, 172:27-31.
27. Lee S.R., Yearwood G.D., Guillon G.B., Kurtz L.A., Fischl M., Friel T., et al. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. J Clin Virol 2010, 48:15-17.
28. Garcia-Costa J., Romero P.A., Soriano V., Sheldon J., Toro C. Seroreversion of hepatitis C virus (HCV) antibodies in an HIV-infected patient despite continuous HCV replication. Clin Infect Dis 2009, 48:1634-1635.
29. Herrero-Martinez E., Sabin C.A., Lee C.A., Jones I.M., Pillay D., Emery V.C. The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response. J Med Virol 2004, 72:187-193.
30. Titanji K., De Milito A., Cagigi A., Thorstensson R., Grutzmeier S., Atlas A., et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006, 108:1580-1587.
31. Drobnik A., Judd C., Banach D., Egger J., Konty K., Rude E. Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations. Am J Public Health 2011, 101:2151-2155.
32. Pavie J., Rachline A., Loze B., Niedbalski L., Delaugerre C., Laforgerie E., et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 2010, 5:e11581.
33. Lucidarme D., Decoster A., Delamare C., Schmitt C., Kozlowski D., Harbonnier J., et al. An inter-laboratory study of anti-HCV antibody detection in saliva samples. Gastroenterol Clin Biol 2003, 27:159-162.